Healthcare

German drug maker Merck KGaA is fighting US drug company Merck Sharp & Dohme over the alleged use of the ‘Merck’ mark in Australia, five years after their intellectual property spat was settled. 

A medical assessment served under the Wrongs Act by a patient of Dr Daniel Lanzer needed to come to the attention of the surgeon himself, not just his solicitors, despite the lawyers being authorised to receive other documents in the case, an appeals court has found. 

A class action against Bupa alleging the aged care provider failed to provide promised levels of care to residents can proceed, with a judge finding the case is not "fatally flawed".

A court has slapped private health insurer Bupa with a $35 million penalty after it admitted to misleading thousands of customers about their benefits for over five years.

Mayne Pharma says it, and not US drug maker Cosette, has terminated their $672 million merger agreement and that it is therefore not on the hook for a break fee.

Setting up another potential legal fight, Mayne Pharma has said US drug maker Cosette did not validly terminate their $672 million merger agreement, which failed to receive FIRB approval.

Ramsay Health Care has lost its challenge to development approval for a community health care services centre near its Greenslopes Hospital in Brisbane, with a court finding the centre would not interfere with the hospital’s operations. 

Johnson & Johnson-owned Janssen has secured an injunction against drug maker Juno Pharmaceuticals, halting the release of Juno's generic version of schizophrenia drug Invega Sustenna.

Nine wants indemnity costs against celebrity surgeon Munjed Al Muderis, claiming his defamation case over reports critical of his promotion of an experimental procedure, which the court found were substantially true, was an abuse of process.

The Full Federal Court has upheld a decision revoking Otsuka Pharmaceuticals’ patent extension for an injectable version of antipsychotic drug Abilify, finding the patent expired last year.